Molecular Targets for Intracranial Aneurysm Treatment
International Journal of Molecular Sciences · 15.10.2025 · 26 (20) · 10053
DOI: 10.3390/ijms262010053 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.10.2025. Verfasst von Hunter Hutchinson und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, University of Florida, Gainesville, FL 32610, USA. Hauptthemen laut MEDLINE: Intracranial Aneurysm, Molecular Targeted Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intracranial aneurysms (IAs) are a common cerebrovascular pathology with deadly potential. Neurointerventionalists commonly treat IAs with endovascular coiling, minimizing procedural risk at the cost of an increased recurrence rate. New therapies for reducing the rate of coiled and uncoiled IA growth and rupture would help reduce the morbidity and mortality patients experience when IAs rupture. Hemodynamic shear stress drives IA formation through molecular mechanisms, generating damage-associated molecular proteins (DAMPs), which lead to inflammation and extracellular matrix remodeling. Nuclear factor κB (NF-κB) and interleukin-6 (IL-6) maintain an inflammatory environment in IA walls, generating immune-cell chemotactic proteins, such as monocyte chemoattractant protein-1 (MCP-1) and IL-8. These molecules play a complex role in IAs, being important for IA formation and IA healing. Vascular smooth muscle cells and infiltrated immune cells secrete matrix metalloproteinases (MMPs), which initiate extracellular matrix remodeling. Tissue inhibitors of matrix metalloproteinases (TIMPs) balance this remodeling. The increased MMP to TIMP ratio is characteristic of IA progression, making these molecules important targets for IA therapies. Endothelial dysfunction generates nitric oxide and other reactive oxygen species, which exacerbate inflammation and cell death in IA walls. A better understanding of molecular mechanisms underlying IA formation, progression, and rupture will allow researchers to develop molecular IA therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, University of Florida, Gainesville, FL 32610, USA.
- Department of Neurosurgery, University of Florida, Gainesville, FL 32608, USA.
ORCID-Profile: Hunter Hutchinson, Rogina Rezk, Abanob Hanna, Brandon Lucke-Wold
Zitieren
APA
Hutchinson, H., Rezk, R., Farag, M., Hanna, A., & Lucke-Wold, B. (2025). Molecular Targets for Intracranial Aneurysm Treatment. International Journal of Molecular Sciences, 26(20), 10053. https://doi.org/10.3390/ijms262010053
Vancouver
Hutchinson H, Rezk R, Farag M, Hanna A, Lucke-Wold B. Molecular Targets for Intracranial Aneurysm Treatment. International Journal of Molecular Sciences. 2025;26(20):10053. doi:10.3390/ijms262010053
BibTeX
@article{Hutchinson2025,
author = {Hutchinson, Hunter and Rezk, Rogina and Farag, Mariam and Hanna, Abanob and Lucke-Wold, Brandon},
title = {Molecular Targets for Intracranial Aneurysm Treatment},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {20},
pages = {10053},
doi = {10.3390/ijms262010053}
}
EUVIMED